NCC to Add Cabozantinib, Valemetostat to Pediatric, AYA Cancer Trial

February 27, 2024
MHLW Panel on Patient-Initiated Care Holds Meeting on Feb. 22 The National Cancer Center (NCC) is set to add two more medicines to its investigator-initiated clinical trial program launched last month for the evaluation of unapproved and off-label drugs to...read more